Charles Schwab
TNYA icon

Charles Schwab’s Tenaya Therapeutics TNYA Stock Holding History

Charles Schwab’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,000
Closed -$34.6K – 3554
2026
Q1 		$34.6K Hold
50,000
– – ﹤0.01% 3438
2025
Q4 		$35.6K Hold
50,000
– – ﹤0.01% 3441
2025
Q3 		$81K Buy
+50,000
New +$50.4K ﹤0.01% 3403
2025
Q2 		– Sell
-130,192
Closed -$74.2K – 3574
2025
Q1 		$74.2K Sell
130,192
-22,396
-15% -$22.1K ﹤0.01% 3369
2024
Q4 		$218K Hold
152,588
– – ﹤0.01% 3316
2024
Q3 		$294K Hold
152,588
– – ﹤0.01% 3287
2024
Q2 		$473K Buy
152,588
+24,468
+19% +$101K ﹤0.01% 3220
2024
Q1 		$670K Buy
128,120
+8,588
+7% +$41.1K ﹤0.01% 2917
2023
Q4 		$387K Hold
119,532
– – ﹤0.01% 3162
2023
Q3 		$305K Hold
119,532
– – ﹤0.01% 3209
2023
Q2 		$702K Buy
119,532
+6,499
+6% +$37.8K ﹤0.01% 2901
2023
Q1 		$322K Buy
113,033
+51,632
+84% +$145K ﹤0.01% 3071
2022
Q4 		$123K Sell
61,401
-4,937
-7% -$12.1K ﹤0.01% 3239
2022
Q3 		$193K Hold
66,338
– – ﹤0.01% 3168
2022
Q2 		$374K Sell
66,338
-2,366
-3% -$19.1K ﹤0.01% 3156
2022
Q1 		$810K Buy
68,704
+33,161
+93% +$401K ﹤0.01% 2933
2021
Q4 		$674K Buy
35,543
+1,332
+4% +$29K ﹤0.01% 3053
2021
Q3 		$707K Buy
+34,211
New +$735K ﹤0.01% 3018

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab's TNYA Position: Q2 2026 in Review

Charles Schwab sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 50,000 shares — an estimated $34.6K sold.

Charles Schwab first reported a position in TNYA in Q3 2021 and held it in 18 quarters. The position peaked at $810K in Q1 2022. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Charles Schwab reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Charles Schwab sold 50,000 Tenaya Therapeutics shares in Q2 2026, an estimated $34.6K.
  • Charles Schwab first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 18 quarters.
  • Charles Schwab's Tenaya Therapeutics position peaked at $810K in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.